Sort By:
Featured

Coronavirus Update

Rochester Clinical Research is following the ever-changing impact of the Coronavirus on a national level and in our local community. Please review our COVID Reopening Patient Access.

View Trial Details
Ages 18+
Study Topics Vaccine Interest

Pneumonia Vaccine

Rochester Clinical Research is currently enrolling generally healthy individuals over 50 years old for a vaccine research study. The study will assess the safety and tolerability of two different dosage levels of study vaccine that may protect against a greater number of strains of pneumococcal disease. The study will last approximately 6 months with two visits to our office and 3 telephone calls.

View Trial Details
Ages 50+
Study Topics Vaccines

E. Coli Vaccine

Rochester Clinical Research is currently enrolling individuals over the age of 60 years old, who have had a UTI within the past 5 years for an E. coli vaccine research study. The study will evaluate the effectiveness of a stud vaccine that may protect against E. coli that could cause sepsis.

View Trial Details
Ages 60+
Study Topics Vaccine

Chikungunya Vaccine

Rochester Clinical Research is participating in a study evaluating the immune response of a single dose of the study Chikungunya vaccine in healthy adults over the age of 18 years old.

View Trial Details
Ages 18+
Study Topics Vaccine

Men’s HPV Vaccine

The purpose of this research study is to determine the efficacy and safety of a 3-dose HPV vaccine in males between the ages of 20- 45. The vaccine aims to prevent HPV infection which are associated with oral cancer. Compensation is available up to $1,300, for those who qualify.

View Trial Details
Ages 20 - 45
Gender For male patients only
Compensation* $1,300
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.